首页> 美国卫生研究院文献>Acta Neuropathologica Communications >Transcriptomic and epigenetic profiling of ‘diffuse midline gliomas H3 K27M-mutant’ discriminate two subgroups based on the type of histone H3 mutated and not supratentorial or infratentorial location
【2h】

Transcriptomic and epigenetic profiling of ‘diffuse midline gliomas H3 K27M-mutant’ discriminate two subgroups based on the type of histone H3 mutated and not supratentorial or infratentorial location

机译:弥散中线神经胶质瘤H3 K27M-突变体的转录组学和表观遗传学分析根据组蛋白H3突变的类型区分了两个亚组而不是幕上或幕下位置

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Diffuse midline glioma (DMG), H3 K27M-mutant, is a new entity in the updated WHO classification grouping together diffuse intrinsic pontine gliomas and infiltrating glial neoplasms of the midline harboring the same canonical mutation at the Lysine 27 of the histones H3 tail.Two hundred and fifteen patients younger than 18 years old with centrally-reviewed pediatric high-grade gliomas (pHGG) were included in this study. Comprehensive transcriptomic (n = 140) and methylation (n = 80) profiling was performed depending on the material available, in order to assess the biological uniqueness of this new entity compared to other midline and hemispheric pHGG.Tumor classification based on gene expression (GE) data highlighted the similarity of K27M DMG independently of their location along the midline. T-distributed Stochastic Neighbor Embedding (tSNE) analysis of methylation profiling confirms the discrimination of DMG from other well defined supratentorial tumor subgroups. Patients with diffuse intrinsic pontine gliomas (DIPG) and thalamic DMG exhibited a similarly poor prognosis (11.1 and 10.8 months median overall survival, respectively). Interestingly, H3.1-K27M and H3.3-K27M primary tumor samples could be distinguished based both on their GE and DNA methylation profiles, suggesting that they might arise from a different precursor or from a different epigenetic reorganization.These differences in DNA methylation profiles were conserved in glioma stem-like cell culture models of DIPG which mimicked their corresponding primary tumor. ChIP-seq profiling of H3K27me3 in these models indicate that H3.3-K27M mutated DIPG stem cells exhibit higher levels of H3K27 trimethylation which are correlated with fewer genes expressed by RNAseq. When considering the global distribution of the H3K27me3 mark, we observed that intergenic regions were more trimethylated in the H3.3-K27M mutated cells compared to the H3.1-K27M mutated ones.H3 K27M-mutant DMG represent a homogenous group of neoplasms compared to other pediatric gliomas that could be further separated based on the type of histone H3 variant mutated and their respective epigenetic landscapes. As these characteristics drive different phenotypes, these findings may have important implication for the design of future trials in these specific types of neoplasms.Electronic supplementary materialThe online version of this article (10.1186/s40478-018-0614-1) contains supplementary material, which is available to authorized users.
机译:弥散中线神经胶质瘤(DMG)为H3 K27M突变体,是经更新的WHO分类中的新实体,将弥散性脑桥神经胶质瘤和中线浸润性胶质瘤合并在一起,在组蛋白H3尾部的赖氨酸27处具有相同的典型突变.2这项研究包括了15例年龄小于18岁的小儿高级别神经胶质瘤(pHGG)进行了中央检查。根据可获得的材料进行了全面的转录组(n = 140)和甲基化(n = fil80)分析,以便评估该新实体与其他中线和半球pHGG相比的生物学独特性。基于基因表达的肿瘤分类(GE )数据突显了K27M DMG的相似性,而与沿中线的位置无关。甲基化分布的T分布随机邻居嵌入(tSNE)分析证实了DMG与其他定义明确的幕上肿瘤亚组的区别。弥漫性桥脑神经胶质瘤(DIPG)和丘脑DMG患者表现出相似的不良预后(分别为中位总生存期11.1和10.8个月)。有趣的是,H3.1-K27M和H3.3-K27M原发性肿瘤样品可以根据其GE和DNA甲基化谱图进行区分,这表明它们可能来自不同的前体或不同的表观遗传重组。在模拟其相应原发肿瘤的DIPG胶质瘤干细胞样细胞培养模型中,这些图谱是保守的。在这些模型中,H3K27me3的ChIP-seq分析表明,H3.3-K27M突变的DIPG干细胞表现出较高水平的H3K27三甲基化,这与RNAseq表达的基因较少有关。当考虑H3K27me3标记的全球分布时,我们观察到与H3.1-K27M突变的细胞相比,H3.3-K27M突变的细胞中的基因间区域更多地被三甲基化。H3 K27M突变的DMG代表了同质的肿瘤组可以根据突变的组蛋白H3变体的类型及其各自的后生情况进一步分离的其他儿童神经胶质瘤。由于这些特征驱动不同的表型,这些发现可能对这些特定类型的肿瘤的未来试验设计具有重要意义。电子补充材料本文的在线版本(10.1186 / s40478-018-0614-1)包含补充材料,其中适用于授权用户。

著录项

相似文献

  • 外文文献
  • 中文文献
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号